It is reported that down-regulation of FABP1 expression, significantly associated with poor differentiation and high expression of β-catenin and glutamine synthetase (GS), caused phenotypic changes during tumor progression in almost 10% of hepatocellular carcinoma (HCC) [22–24]. The gene discussed is FABP1; the disease is neoplasm.